114 related articles for article (PubMed ID: 21854795)
1. Reduction of isoprenaline-induced myocardial TGF-β1 expression and fibrosis in osthole-treated mice.
Chen R; Xue J; Xie ML
Toxicol Appl Pharmacol; 2011 Oct; 256(2):168-73. PubMed ID: 21854795
[TBL] [Abstract][Full Text] [Related]
2. Puerarin prevents isoprenaline-induced myocardial fibrosis in mice by reduction of myocardial TGF-β1 expression.
Chen R; Xue J; Xie M
J Nutr Biochem; 2012 Sep; 23(9):1080-5. PubMed ID: 22079205
[TBL] [Abstract][Full Text] [Related]
3. Osthole regulates TGF-β1 and MMP-2/9 expressions via activation of PPARα/γ in cultured mouse cardiac fibroblasts stimulated with angiotensin II.
Chen R; Xue J; Xie M
J Pharm Pharm Sci; 2013; 16(5):732-41. PubMed ID: 24393555
[TBL] [Abstract][Full Text] [Related]
4. Osthole inhibits the expressions of collagen I and III through Smad signaling pathway after treatment with TGF-β1 in mouse cardiac fibroblasts.
Liu JC; Wang F; Xie ML; Cheng ZQ; Qin Q; Chen L; Chen R
Int J Cardiol; 2017 Feb; 228():388-393. PubMed ID: 27870967
[TBL] [Abstract][Full Text] [Related]
5. Osthole improves fat milk-induced fatty liver in rats: modulation of hepatic PPAR-alpha/gamma-mediated lipogenic gene expression.
Zhang Y; Xie M; Xue J; Gu Z
Planta Med; 2007 Jul; 73(8):718-24. PubMed ID: 17611927
[TBL] [Abstract][Full Text] [Related]
6. Osthole, a potential antidiabetic agent, alleviates hyperglycemia in db/db mice.
Liang HJ; Suk FM; Wang CK; Hung LF; Liu DZ; Chen NQ; Chen YC; Chang CC; Liang YC
Chem Biol Interact; 2009 Oct; 181(3):309-15. PubMed ID: 19682441
[TBL] [Abstract][Full Text] [Related]
7. Fluvastatin decreases cardiac fibrosis possibly through regulation of TGF-beta(1)/Smad 7 expression in the spontaneously hypertensive rats.
Zhai Y; Gao X; Wu Q; Peng L; Lin J; Zuo Z
Eur J Pharmacol; 2008 Jun; 587(1-3):196-203. PubMed ID: 18430418
[TBL] [Abstract][Full Text] [Related]
8. Effects of RNA interference targeting transforming growth factor-beta 1 on immune hepatic fibrosis induced by Concanavalin A in mice.
Xu W; Wang LW; Shi JZ; Gong ZJ
Hepatobiliary Pancreat Dis Int; 2009 Jun; 8(3):300-8. PubMed ID: 19502172
[TBL] [Abstract][Full Text] [Related]
9. Troglitazone suppresses transforming growth factor-beta1-induced collagen type I expression in keloid fibroblasts.
Zhang GY; Yi CG; Li X; Ma B; Li ZJ; Chen XL; Guo SZ; Gao WY
Br J Dermatol; 2009 Apr; 160(4):762-70. PubMed ID: 19120328
[TBL] [Abstract][Full Text] [Related]
10. Osthole decreases collagen I/III contents and their ratio in TGF-β1-overexpressed mouse cardiac fibroblasts through regulating the TGF-β/Smad signaling pathway.
Liu JC; Zhou L; Wang F; Cheng ZQ; Rong C
Chin J Nat Med; 2018 May; 16(5):321-329. PubMed ID: 29860992
[TBL] [Abstract][Full Text] [Related]
11. Osthole inhibits inflammatory cytokine release through PPARα/γ-mediated mechanisms in LPS-stimulated 3T3-L1 adipocytes.
Wang XL; Shang X; Cui Y; Zhao X; Zhang Y; Xie ML
Immunopharmacol Immunotoxicol; 2015 Apr; 37(2):185-92. PubMed ID: 25689951
[TBL] [Abstract][Full Text] [Related]
12. Osthole ameliorates hepatic fibrosis and inhibits hepatic stellate cell activation.
Liu YW; Chiu YT; Fu SL; Huang YT
J Biomed Sci; 2015 Aug; 22(1):63. PubMed ID: 26231226
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of liver fibrosis by solubilized coenzyme Q10: Role of Nrf2 activation in inhibiting transforming growth factor-beta1 expression.
Choi HK; Pokharel YR; Lim SC; Han HK; Ryu CS; Kim SK; Kwak MK; Kang KW
Toxicol Appl Pharmacol; 2009 Nov; 240(3):377-84. PubMed ID: 19647758
[TBL] [Abstract][Full Text] [Related]
14. Troglitazone inhibits synthesis of transforming growth factor-beta1 and reduces matrix production in human peritoneal mesothelial cells.
Peng Y; Liu H; Liu F; Liu Y; Li J; Chen X
Nephrology (Carlton); 2006 Dec; 11(6):516-23. PubMed ID: 17199790
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory effect of osthole on alcohol-induced fatty liver in mice.
Sun F; Xie ML; Zhu LJ; Xue J; Gu ZL
Dig Liver Dis; 2009 Feb; 41(2):127-33. PubMed ID: 18339590
[TBL] [Abstract][Full Text] [Related]
16. Triptolide alleviates isoprenaline-induced cardiac remodeling in rats via TGF-β1/Smad3 and p38 MAPK signaling pathway.
Liu M; Chen J; Huang Y; Ke J; Li L; Huang D; Wu W
Pharmazie; 2015 Apr; 70(4):244-50. PubMed ID: 26012254
[TBL] [Abstract][Full Text] [Related]
17. Defective processing of the transforming growth factor-beta1 in azoxymethane-induced mouse colon tumors.
Guda K; Claffey KP; Dong M; Nambiar PR; Rosenberg DW
Mol Carcinog; 2003 May; 37(1):51-9. PubMed ID: 12720300
[TBL] [Abstract][Full Text] [Related]
18. L-Carnitine protects against arterial hypertension-related cardiac fibrosis through modulation of PPAR-γ expression.
Zambrano S; Blanca AJ; Ruiz-Armenta MV; Miguel-Carrasco JL; Arévalo M; Vázquez MJ; Mate A; Vázquez CM
Biochem Pharmacol; 2013 Apr; 85(7):937-44. PubMed ID: 23295156
[TBL] [Abstract][Full Text] [Related]
19. Feitai, a Chinese herbal medicine, reduces transforming growth factor-beta1 and monocyte chemoattractant protein-1 expression in bleomycin-induced lung fibrosis in mice.
Shen Y; Zhao HL; Du J; Li YT; Tan F; Huang CG; Pei G
Clin Exp Pharmacol Physiol; 2005 Dec; 32(12):1071-7. PubMed ID: 16445573
[TBL] [Abstract][Full Text] [Related]
20. [Mechanism of reversion of myocardial interstitial fibrosis in diabetic cardiomyopathy by valsartan].
Zhong M; Zhang Y; Miao Y; Li L; Gong HP; Ma X; Sun H; Zhang W
Zhonghua Yi Xue Za Zhi; 2006 Jan; 86(4):232-6. PubMed ID: 16677501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
